Insider filing · KRYS
Kathryn Romano
Chief Accounting Officer
profile →
Krystal Biotech, Inc.
KRYS · Healthcare · 25 filings in 24 months
ticker →
Kathryn Romano sold $3.4M of Krystal Biotech (KRYS)
Executed Feb 9, disclosed Feb 11, 2 days later.
Value, as filed
$3.4M
12,404 sh across 6 lots
Executed
Feb 9
the trade date, as filed
Disclosed
Feb 11
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KRKathryn Romano (Chief Accounting Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Krystal Biotech, Inc. (KRYS). The largest single filing was $3.4M of KRYS (12,404 sh across 6 lots, as filed), executed Feb 9.
The name
KRYSHealthcare · Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Kathryn Romano in KRYS
KRYSSALE
Krystal Biotech, Inc.
$201K750 sh × $267.60
Exec Mar 2
Filed Mar 3 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. $131K
750 sh × $175.22
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET